Model Medicines key facts
as of Oct 2026- Developer of an artificial intelligence-driven drug discovery platform designed to accelerate the creation of life-changing drugs.
- Model Medicines is valued at approximately $81.3M as of Oct 2026, set at its seed round, Nov 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $18.8M across 4 recorded rounds; the latest was Seed Round ($3.3M) in Oct 2025.
- Notable investors include 8VC, BioTools Innovator, Irving Investors, Triton Funds, Thermopolis Partners — 8 tracked in total.
- Model Medicines has filed 4 Form Ds with the SEC since 2021, most recently Nov 2025 ($3.3M sold to 10 investors).
- Status: Privately Held (backing).
Valued at $81.3M at its seed round, Nov 2025. Nothing has traded since.
- ·Watch Model Medicines: the Monday email on marks, rounds and moves
Model Medicines funding rounds
4 roundsModel Medicines valuation
Model Medicines was valued at $81.3 million at its seed round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Model Medicines raised?
Model Medicines has raised $18.8 million across 4 recorded rounds since 2020. The largest was a $950,000 seed round in Dec 2023; the most recent was a $3.3 million seed round in Oct 2025.
Model Medicines has filed 4 Form Ds with the SEC since 2021, most recently in Nov 2025 ($3.3 million sold to 10 investors).
Model Medicines investors
8 investors are on record for Model Medicines, including 8VC, BioTools Innovator, Irving Investors and Triton Funds. The seed round in Oct 2025 drew 10 investors.
About Model Medicines
Developer of an artificial intelligence-driven drug discovery platform designed to accelerate the creation of life-changing drugs. The company offers a developed pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, gastric disorders, neurological disorders, and communicable diseases to develop drugs, enabling healthcare institutions to create better medicines tailored to patients' needs.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2019
- Employees
- 13
- Website
- modelmedicines.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.